# Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

> **NCT00107731** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 710 (—)

## Conditions studied

- Bipolar I Disorder

## Interventions

- **DRUG:** quetiapine fumarate
- **DRUG:** lithium
- **DRUG:** divalproex

## Key facts

- **NCT ID:** NCT00107731
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 710 (—)
- **Last updated:** 2009-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107731, "Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00107731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*